Market Value1,499,090,000
Total Holdings64
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HYPR / Hyperfine, Inc.
HCA / HCA Healthcare, Inc.
SYK / Stryker Corporation
COO / The Cooper Companies, Inc.
CCXI / ChemoCentryx Inc
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund
JNJ / Johnson & Johnson
CNC / Centene Corporation
LGV.WS / Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of C
US26886C1154 / EQRx Inc
US68626A1161 / ORION ACQUISITION CORP WT EXP 021926
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
KYG5960S1241 / Medicus Sciences Acquisition Corp.
MDT / Medtronic plc
RACB / Research Alliance Corp II - Class A
IMGN / ImmunoGen, Inc.
ALKS / Alkermes plc
BBIO / BridgeBio Pharma, Inc. Call
ABBV / AbbVie Inc.
REGN / Regeneron Pharmaceuticals, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AXNX / Axonics, Inc.
AMGN / Amgen Inc.
DHR / Danaher Corporation
ABC / Amerisource Bergen Corp.
ELV / Elevance Health, Inc.
UNH / UnitedHealth Group Incorporated
BSX / Boston Scientific Corporation
CVS / CVS Health Corporation
DICE / DICE Therapeutics Inc
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
HALO / Halozyme Therapeutics, Inc.
NVRO / Nevro Corp.
LGV / Longview Acquisition Corp II - Class A
AVTR / Avantor, Inc.
SGEN / Seagen Inc
NVST / Envista Holdings Corporation
HSIC / Henry Schein, Inc.
INSP / Inspire Medical Systems, Inc.
STXS / Stereotaxis, Inc.
UHS / Universal Health Services, Inc.
ABT / Abbott Laboratories
BIIB / Biogen Inc.
BMY / Bristol-Myers Squibb Company
QTRX / Quanterix Corporation
RAPT / RAPT Therapeutics, Inc.
GERN / Geron Corporation
PCRX / Pacira BioSciences, Inc.
INCY / Incyte Corporation
CAH / Cardinal Health, Inc.
PYXS / Pyxis Oncology, Inc.
RVNC / Revance Therapeutics, Inc.
VCYT / Veracyte, Inc.
LPTX / Leap Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
MDT / Medtronic plc Call
ITCI / Intra-Cellular Therapies, Inc.
TFX / Teleflex Incorporated
CANO / Cano Health, Inc.
ARYE / ARYA Sciences Acquisition Corp V - Class A
MRVI / Maravai LifeSciences Holdings, Inc.
OHPA / Orion Acquisition Corp - Class A
IBB / iShares Trust - iShares Biotechnology ETF
WOOF / Petco Health and Wellness Company, Inc.
MCK / McKesson Corporation
AFMD / Affimed N.V.
HZNP / Horizon Therapeutics Plc
MRUS / Merus N.V.
CYTK / Cytokinetics, Incorporated
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
IKNA / Ikena Oncology, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
HUM / Humana Inc.
LIVN / LivaNova PLC
THC / Tenet Healthcare Corporation
BDX / Becton, Dickinson and Company
PFE / Pfizer Inc.
NBIX / Neurocrine Biosciences, Inc.
NTRA / Natera, Inc.
BMRN / BioMarin Pharmaceutical Inc.